{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:53:59Z","timestamp":1787068439733,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"tehran university of medical sciences and health services","doi-asserted-by":"publisher","award":["9111215259"],"award-info":[{"award-number":["9111215259"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      , a human skin and mucous membranes colonizer, could opportunistically cause a variety of infectious diseases. Frequently, it is resistant to methicillin (MRSA), and often, co-resistant to many clinically available antibiotics. MRSA is a major burden for healthcare systems and communities all over the world, especially in developing countries. We addressed the issue that more than a decade had passed since the last report about cumulative antibiogram for\n                      <jats:italic>S. aureus<\/jats:italic>\n                      from our center, whereas The Clinical and Laboratory Standards Institute (CLSI) recommends to analyze and report it on an annual basis in order to guide clinicians to select the best initial empiric antimicrobial therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In a cross-sectional retrospective design, data of culture-proven\n                      <jats:italic>S. aureus<\/jats:italic>\n                      from clinical specimens of hospitalized patients at Imam Khomeini Hospital Complex, Tehran, Iran, were collected from September 2018 to September 2019. Antimicrobial susceptibility testing (AST) had been performed using either Kirby\u2013Bauer disk diffusion or VITEK 2 automated system which is based on minimum inhibitory concentration (MIC). The Chi-squared test was used considering the critical\n                      <jats:italic>p<\/jats:italic>\n                      -value to be\u2009\u2264\u2009.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 576 unique isolates, the overall prevalence of MRSA was 37.5%. Patients admitted to the infectious diseases ward and ICUs have a greater chance to have such an isolate. Methicillin resistance was predictive of resistance to most antibiotics: erythromycin (90.9%), clindamycin (85.4% including inducible resistance), gentamicin, cipro-\/levo-\/moxi-floxacin, trimethoprim\u2013sulfamethoxazole (58.3%), tetracycline, and rifampin. Resistance rate of zero was observed for daptomycin, linezolid, tigecycline, and (roughly) vancomycin. The prevalence of multiple-drug resistant (MDR) isolates was 48.5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although in this study, the prevalence of MRSA was lower than the previous ones from the same hospital, it is still far from the desired rates. Besides, resistance to clindamycin and trimethoprim\u2013sulfamethoxazole were remarkable. So far, vancomycin is the best choice for empiric treatment of MRSA, with linezolid as the second choice. It is advised to avoid prescribing the newer antibacterial agents as long as the older ones are effective to prevent the emergence of MDR species.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-022-00778-w","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T02:02:58Z","timestamp":1660701778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antimicrobial susceptibility testing of Staphylococcus aureus isolates from patients at a tertiary hospital in Tehran, Iran, 2018\u20132019"],"prefix":"10.1186","volume":"27","author":[{"given":"Mohammad","family":"Qodrati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeyedAhmad","family":"SeyedAlinaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-2950","authenticated-orcid":false,"given":"Seyed Ali","family":"Dehghan Manshadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Dadras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"778_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD. Staphylococcus aureus Infections. N Engl J Med. 1998;339:520\u201332.","journal-title":"N Engl J Med"},{"key":"778_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jhin.2008.10.001","volume":"70","author":"SWB Newsom","year":"2008","unstructured":"Newsom SWB. Ogston\u2019s coccus. J Hosp Infect. 2008;70:369\u201372.","journal-title":"J Hosp Infect"},{"key":"778_CR3","doi-asserted-by":"crossref","unstructured":"Fairbrother RW. Staphylococcus, micrococcus and Sarcina staphylococcus. In: A text-book of medical bacteriology. Elsevier; 2014. p. 147\u2013155.","DOI":"10.1016\/B978-1-4832-0032-3.50017-5"},{"key":"778_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","volume":"1","author":"MP Jevons","year":"1961","unstructured":"Jevons MP. \u201cCelbenin\u201d\u2014resistant Staphylococci. Br Med J. 1961;1:124\u20135.","journal-title":"Br Med J"},{"key":"778_CR5","first-page":"624","volume":"46","author":"Centers for Disease Control and Prevention CDC","year":"1997","unstructured":"Centers for Disease Control and Prevention CDC. Reduced susceptibility of Staphylococcus aureus to vancomycin\u2013Japan, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:624\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"778_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1476-0711-5-30","volume":"5","author":"MM Baddour","year":"2006","unstructured":"Baddour MM, Abuelkheir MM, Fatani AJ. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann Clin Microbiol Antimicrob. 2006;5:30.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"778_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"778_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2020.1755550","author":"P Waitayangkoon","year":"2020","unstructured":"Waitayangkoon P, Thongkam A, Benjamungkalarak T, Rachayon M, Thongthaisin A, Chatsuwan T, Thammahong A, Chiewchengchol D. Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a one-year retrospective study at a tertiary care center in Thailand. Pathog Glob Health. 2020. https:\/\/doi.org\/10.1080\/20477724.2020.1755550.","journal-title":"Pathog Glob Health"},{"key":"778_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12879-016-1742-5","volume":"16","author":"T Dilnessa","year":"2016","unstructured":"Dilnessa T, Bitew A. Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia. BMC Infect Dis. 2016;16:398.","journal-title":"BMC Infect Dis"},{"key":"778_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/femsre\/fux007","volume":"41","author":"TJ Foster","year":"2017","unstructured":"Foster TJ. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev. 2017;41:430\u201349.","journal-title":"FEMS Microbiol Rev"},{"key":"778_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40121-014-0023-0","volume":"3","author":"KE Barber","year":"2014","unstructured":"Barber KE, Ireland CE, Bukavyn N, Rybak MJ. Observation of \u201cseesaw effect\u201d with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains. Infect Dis Ther. 2014;3:35\u201343.","journal-title":"Infect Dis Ther"},{"key":"778_CR12","unstructured":"Hindler JA, Clinical and Laboratory Standards Institute (eds). Analysis and presentation of cumulative antimicrobial susceptibility test data\u202f; approved guideline, 4th edn. Wayne, PA: Committee for Clinical Laboratory Standards; 2014."},{"key":"778_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1086\/511864","volume":"44","author":"JF Hindler","year":"2007","unstructured":"Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis. 2007;44:867\u201373.","journal-title":"Clin Infect Dis"},{"key":"778_CR14","unstructured":"Weinstein MP, Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: supplement M100. Wayne, Pa.: Clinical and Laboratory Standards Institute; 2010."},{"key":"778_CR15","first-page":"141","volume":"6","author":"SJ Siyahkali","year":"2018","unstructured":"Siyahkali SJ, Dadras O, Zoha AL, Seyedalinaghi S, Hejazi N. Evaluation of sensitivity and specificity of the method cefoxitin-disk diffusion in detection of methicillin-resistant Staphylococcus aureus in clinical samples of two hospitals, Tehran, Iran. J Int Transl Med. 2018;6:141\u20133.","journal-title":"J Int Transl Med"},{"key":"778_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/1471-2334-13-569","volume":"13","author":"DA Williamson","year":"2013","unstructured":"Williamson DA, Lim A, Thomas MG, Baker MG, Roberts SA, Fraser JD, Ritchie SR. Incidence, trends and demographics of Staphylococcus aureus infections in Auckland, New Zealand, 2001\u20132011. BMC Infect Dis. 2013;13:569.","journal-title":"BMC Infect Dis"},{"key":"778_CR17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1128\/AAC.48.4.1124-1127.2004","volume":"48","author":"HB Kim","year":"2004","unstructured":"Kim HB, Jang H-C, Nam HJ, Lee YS, Kim BS, Park WB, Lee KD, Choi YJ, Park SW, Oh M-D, Kim E-C, Choe KW. In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother. 2004;48:1124\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"778_CR18","first-page":"125","volume":"6","author":"H Khalili","year":"2010","unstructured":"Khalili H, Soltani R, Gholami K, Rasoolinejad M, Abdollahi A. Antimicrobial susceptibility pattern of Staphylococcus aureus strains isolated from hospitalized patients in Tehran, Iran. Iran J Pharm Sci. 2010;6:125\u201332.","journal-title":"Iran J Pharm Sci"},{"key":"778_CR19","first-page":"182","volume":"61","author":"M Mohraz","year":"2003","unstructured":"Mohraz M, Jonaidi N, Rasoulinejad M, Broum MA, Aligholi M, Shahsavan SH. Determination of prevalence of methicillin resistant Staphylococcus Infections through measurement of mics of S. aureus isolates Imam Hospital (November 2001 to January 2003). Tehran Univ Med J. 2003;61:182\u201392.","journal-title":"Tehran Univ Med J"},{"key":"778_CR20","first-page":"1010","volume":"15","author":"E Askari","year":"2012","unstructured":"Askari E, Soleymani F, Arianpoor A, Tabatabai SM, Amini A, Naderinasab M. Epidemiology of mecA-methicillin resistant Staphylococcus aureus (MRSA) in Iran: a systematic review and meta-analysis. Iran J Basic Med Sci. 2012;15:1010\u20139.","journal-title":"Iran J Basic Med Sci"},{"key":"778_CR21","first-page":"24","volume":"40","author":"D Yadegarynia","year":"2016","unstructured":"Yadegarynia D, Taheri M, Arabmazar Z, Darvishi A. Evaluation of antimicrobial susceptibility among Staphylococcus aureus by E-test Method at Khatam-Ol-Anbia Hospital during 2013\u20132015. Res Med. 2016;40:24\u20139.","journal-title":"Res Med"},{"key":"778_CR22","unstructured":"Surveillance of antimicrobial resistance in Europe 2018. European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2018. 2019. Accessed 17 May 2020."},{"key":"778_CR23","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.41666","author":"R RashidiNezhad","year":"2017","unstructured":"RashidiNezhad R, Meybodi SM, Rezaee R, Goudarzi M, Fazeli M. Molecular characterization and resistance profile of methicillin resistant Staphylococcus aureus strains isolated from hospitalized patients in intensive care unit, Tehran-Iran. Jundishapur J Microbiol. 2017. https:\/\/doi.org\/10.5812\/jjm.41666 (Epub ahead of print 1 January 2017).","journal-title":"Jundishapur J Microbiol."},{"key":"778_CR24","unstructured":"Healthcare-associated infections in intensive care units\u2014Annual Epidemiological Report for 2017. European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/healthcare-associated-infections-intensive-care-units-annual-epidemiological-1. 2019. Accessed 17 May 2020."},{"key":"778_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12879-017-2844-4","volume":"17","author":"HM Naimi","year":"2017","unstructured":"Naimi HM, Rasekh H, Noori AZ, Bahaduri MA. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. BMC Infect Dis. 2017;17:737.","journal-title":"BMC Infect Dis"},{"key":"778_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fmed.2020.00127","volume":"7","author":"X Ai","year":"2020","unstructured":"Ai X, Gao F, Yao S, Liang B, Mai J, Xiong Z, Chen X, Liang Z, Yang H, Ou Z, Gong S, Long Y, Zhou Z. Prevalence, characterization, and drug resistance of Staphylococcus aureus in feces from pediatric patients in Guangzhou, China. Front Med (Lausanne). 2020;7:127.","journal-title":"Front Med (Lausanne)"},{"key":"778_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230383","author":"H Ma","year":"2020","unstructured":"Ma H, Cheng J, Peng L, Gao Y, Zhang G, Luo Z. Adjunctive rifampin for the treatment of Staphylococcus aureus\u00a0bacteremia with deep infections: a meta-analysis. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0230383 (Epub ahead of print 19 March 2020).","journal-title":"PLoS ONE"},{"key":"778_CR28","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"778_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000141513","volume":"17","author":"M Aligholi","year":"2008","unstructured":"Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract. 2008;17:432\u20134.","journal-title":"Med Princ Pract"},{"key":"778_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2018.06.018","author":"N Baseri","year":"2018","unstructured":"Baseri N, Najar-Peerayeh S, Bagheri AF. The prevalence of vancomycin-intermediate Staphylococcus aureus in clinical isolates in Iran: a Systematic Review and meta-analysis. J Glob Antimicrob Resist. 2018. https:\/\/doi.org\/10.1016\/j.jgar.2018.06.018 (Epub ahead of print 4 July 2018).","journal-title":"J Glob Antimicrob Resist."},{"issue":"Suppl 5","key":"778_CR31","first-page":"S106","volume":"89","author":"S Mekviwattanawong","year":"2006","unstructured":"Mekviwattanawong S, Srifuengfung S, Chokepaibulkit K, Lohsiriwat D, Thamlikitkul V. Epidemiology of Staphylococcus aureus infections and the prevalence of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in hospitalized patients at Siriraj Hospital. J Med Assoc Thai. 2006;89(Suppl 5):S106-117.","journal-title":"J Med Assoc Thai"},{"key":"778_CR32","first-page":"163","volume":"6","author":"S Dibah","year":"2014","unstructured":"Dibah S, Arzanlou M, Jannati E, Shapouri R. Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran. Iran J Microbiol. 2014;6:163\u20138.","journal-title":"Iran J Microbiol"},{"key":"778_CR33","unstructured":"Research Ethics Committees Certificate. National Committee for Ethics in Biomedical Research. https:\/\/ethics.research.ac.ir\/ProposalCertificateEn.php?id=31548. Accessed 6 Jun 2021."}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00778-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T02:07:17Z","timestamp":1660702037000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00778-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00778-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As an observational study without any additional intervention on participants, the project was evaluated by the Biomedical Research Ethics Committee of Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, and found to be in accordance with the ethical principles, and the national norms and standards for conducting Medical Research in Iran. The approval ID is IR.TUMS.IKHC.REC.1397.201 and the ethics certificate is accessible on the web [\n                      \n                      ]. Informed consent regarding the use of medical records was obtained from each participant or their parent\/guardian at the time of hospital admission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}